Trial Outcomes & Findings for Phase IV Study of the Impact of Dietary Fibers on Symptoms and Esophageal Motility in Patients With Non-erosive GERD (NCT NCT01882088)
NCT ID: NCT01882088
Last Updated: 2019-08-13
Results Overview
Number of gastroesophageal refluxes registered with 24-hours esophageal pH-impedance on the 10th day of psyllium intake. Statistical data represent the results of the comparison of the data obtained on the day 10 of study (EOT) with the baseline characteristics provided in the specific section
COMPLETED
PHASE4
36 participants
End of Treatment, on day 10 of psyllium intake
2019-08-13
Participant Flow
36 patients were enrolled. 1 patient withdrew informed consent before day 0, 1 excluded due to non-compliance, 1 could not tolerate oesophageal manometry, in 1 case there was no possibility to perform the manometry. Migration of the pH-impedance probe was found in two patients. The data of these mentioned 6 patients were excluded from the analysis
Participant milestones
| Measure |
Mucofalk
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Overall Study
STARTED
|
35
|
|
Overall Study
COMPLETED
|
30
|
|
Overall Study
NOT COMPLETED
|
5
|
Reasons for withdrawal
| Measure |
Mucofalk
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Overall Study
Intolerance of esophageal manometry
|
1
|
|
Overall Study
no possibility to place the catheter
|
1
|
|
Overall Study
Protocol Violation
|
1
|
|
Overall Study
inadequate pH-impedance tracings
|
2
|
Baseline Characteristics
out of those who had hiatal hernia
Baseline characteristics by cohort
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Age, Continuous
|
34.7 years
STANDARD_DEVIATION 9.3 • n=30 Participants
|
|
Sex: Female, Male
Female
|
12 Participants
n=30 Participants
|
|
Sex: Female, Male
Male
|
18 Participants
n=30 Participants
|
|
Race (NIH/OMB)
American Indian or Alaska Native
|
0 Participants
n=30 Participants
|
|
Race (NIH/OMB)
Asian
|
0 Participants
n=30 Participants
|
|
Race (NIH/OMB)
Native Hawaiian or Other Pacific Islander
|
0 Participants
n=30 Participants
|
|
Race (NIH/OMB)
Black or African American
|
0 Participants
n=30 Participants
|
|
Race (NIH/OMB)
White
|
30 Participants
n=30 Participants
|
|
Race (NIH/OMB)
More than one race
|
0 Participants
n=30 Participants
|
|
Race (NIH/OMB)
Unknown or Not Reported
|
0 Participants
n=30 Participants
|
|
Region of Enrollment
Russia
|
30 participants
n=30 Participants
|
|
body mass index, kg/m^2
|
36.7 kg/m^2
STANDARD_DEVIATION 6.9 • n=30 Participants
|
|
weight, kg
|
82.5 kg
STANDARD_DEVIATION 17.9 • n=30 Participants
|
|
smoking status (yes)
|
6 Participants
n=30 Participants
|
|
alcohol intake (yes)
|
14 Participants
n=30 Participants
|
|
alcohol use (g/day)
|
1.1 g/day
STANDARD_DEVIATION 1.7 • n=30 Participants
|
|
basal dietary fiber intake, g/day
|
6.0 g/day
STANDARD_DEVIATION 2.3 • n=30 Participants
|
|
hiatal hernia presence
|
16 Participants
n=30 Participants
|
|
hiatal hernia size
|
0.9 cm
STANDARD_DEVIATION 0.5 • n=16 Participants • out of those who had hiatal hernia
|
|
stools per week, n
|
7.0 stools per week
STANDARD_DEVIATION 2.0 • n=30 Participants
|
|
Number of Gastroesophageal Refluxes
|
67.9 refluxes a day
STANDARD_DEVIATION 17.7 • n=30 Participants
|
|
Acid exposure time
|
5.6 Percent of time pH<4 per 24-hours period
STANDARD_DEVIATION 4.8 • n=30 Participants
|
|
Number of acid gastroesophageal refluxes
|
43.2 acid refluxes per day
STANDARD_DEVIATION 14.7 • n=30 Participants
|
|
Number of patients experiencing heartburn during 7 days prior to baseline
|
28 Participants
n=30 Participants
|
|
minimal lower esophageal sphincter pressure at rest, mm Hg
|
22.0 mm Hg
STANDARD_DEVIATION 9.4 • n=30 Participants
|
|
Mean resting lower esophageal sphincter (LES) pressure after 10 water swallows
|
20.5 mm Hg
STANDARD_DEVIATION 9.5 • n=30 Participants
|
|
Minimal Resting Lower Esophageal Sphincter (LES) Pressure After 10 Water Swallows
|
14.1 mm Hg
STANDARD_DEVIATION 8.0 • n=30 Participants
|
|
Residual Lower Esophageal Sphincter Pressure
|
7.5 mm Hg
STANDARD_DEVIATION 6.1 • n=30 Participants
|
|
Mean Lower Esophageal Sphincter Pressure (at Rest)
|
22.0 mm Hg
STANDARD_DEVIATION 9.4 • n=30 Participants
|
PRIMARY outcome
Timeframe: End of Treatment, on day 10 of psyllium intakePopulation: Thirty-six patients were enrolled, complete data from 30 were included in the final analysis.
Number of gastroesophageal refluxes registered with 24-hours esophageal pH-impedance on the 10th day of psyllium intake. Statistical data represent the results of the comparison of the data obtained on the day 10 of study (EOT) with the baseline characteristics provided in the specific section
Outcome measures
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Number of Gastroesophageal Refluxes
|
42.4 refluxes
Standard Deviation 13.5
|
SECONDARY outcome
Timeframe: End of Treatment, on day 10 of psyllium intakePopulation: Thirty-six patients were enrolled, complete data from 30 were included in the final analysis.
Percent of time with pH less than 4 at 5 cm above upper border of lower oesophageal sphincter per 24-hours oesophageal pH-impedance recording on the day 10 of psyllium intake. This outcome measure was compared to the baseline characteristics provided in the specific section of the study description
Outcome measures
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Acid Exposure Time
|
5.5 Percent of time pH<4 per 24-hours period
Standard Deviation 7.57
|
SECONDARY outcome
Timeframe: End of Treatment, on day 10 of psyllium intakePopulation: 36 subjects were enrolled, data of 30 of them were included to the final analysis
Number of acid refluxes was measured by 24-hours oesophageal pH-impedance recordings. Reflux was considered as acid when oesophageal pH was less than 4 and the impedance revealed backward flow of the stomach content into the oesophagus. Outcome measure reflects the data of day 10 of psyllium intake. Statistics reflects comparison between EOT and baseline data.
Outcome measures
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Number of Acid Gastroesophageal Refluxes
|
30.3 acid refluxes
Standard Deviation 15.3
|
SECONDARY outcome
Timeframe: 7 days prior to EOTPopulation: 36 patients were enrolled, data of 30 of them were included to the final analysis
Presence of heartburn during 7 days prior to the day 10 of psyllium intake was evaluated with a standardized questionnaire. This result was assessed at EOT
Outcome measures
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Number of Patients Experiencing Heartburn During 7 Days Prior the Day 10 of Psyllium Intake
|
12 Number of participants
|
SECONDARY outcome
Timeframe: End of Treatment, on day 10 of psyllium intakePopulation: 36 patients were enrolled. data of the 30 of them were available for the final analysis
Obtained during esophageal high resolution manometry study. End of treatment data were compared to the baseline. Per standard, resting pressure is measured during 30 seconds. High resolution manometry data on day 10 was compared to baseline.
Outcome measures
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Minimal Lower Esophageal Sphincter Pressure at Rest
|
11.3 mm Hg
Standard Deviation 9.4
|
SECONDARY outcome
Timeframe: End of Treatment, on day 10 of psyllium intakePopulation: 36 patients enrolled, data of the 30 of them were available for the final analysis
The data are obtained during high resolution esophageal manometry study on the day 10 of psyllium intake. This outcome is measured after 10 water swallows by 5 ml each. The study usually lasts for about 15 to 20 minutes. Data of high-resolution esophageal manometry examination at baseline and on the day 10 of psyllium intake were compared.
Outcome measures
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Mean Resting Lower Esophageal Sphincter (LES) Pressure After 10 Water Swallows at the End of Treatment (the Day 10 of Psyllium Intake)
|
22.0 mm Hg
Standard Deviation 10.3
|
SECONDARY outcome
Timeframe: End of Treatment, on day 10 of psyllium intakePopulation: 36 patients were enrolled, data of 30 of them were available for the final analysis
The results obtained during high resolution esophageal manometry studies. This parameter is obtained after 10 water swallows by 5 ml each. Data of high resolution esophageal manometry (examination usually lasts for 10-20 min) on the day 10 of psyllium intake were compared to the baseline characteristics. The data were compared to baseline characteristics
Outcome measures
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Minimal Resting Lower Esophageal Sphincter (LES) Pressure After 10 Water Swallows
|
14.9 mm Hg
Standard Deviation 6.4
|
SECONDARY outcome
Timeframe: End of Treatment, on day 10 of psyllium intakePopulation: 36 non-erosive reflux disease (NERD) patients were enrolled, the data of 30 of them were available for the final analysis
These data are obtained during high resolution esophageal manometry studies. The end of treatment characteristics were compared to the baseline ones.
Outcome measures
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Residual Lower Esophageal Sphincter Pressure
|
7.0 mm Hg
Standard Deviation 5.4
|
OTHER_PRE_SPECIFIED outcome
Timeframe: End of Treatment, on day 10 of psyllium intakePopulation: 36 subjects were enrolled, data of 30 of them were available for the final analysis
This parameter is obtained with the use of high-resolution esophageal manometry performed on the Day 10 of psyllium intake.
Outcome measures
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Mean Lower Esophageal Sphincter Pressure (at Rest)
|
26.5 mm Hg
Standard Deviation 11.3
|
OTHER_PRE_SPECIFIED outcome
Timeframe: 7 daysPopulation: 36 patients were enrolled, complete data of 30 of them were available for the final analysis
Episodes of stools were calculated during 7-day period. Mean number at the end point was compared to the baseline one
Outcome measures
| Measure |
Mucofalk
n=30 Participants
Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
Mucofalk: Mucofalk 15 g/day i.e. 5 g TID per os, 15-20 min before meal
|
|---|---|
|
Stools Per Week
|
8.0 stools per week
Standard Deviation 3.0
|
Adverse Events
Mucofalk
Serious adverse events
Adverse event data not reported
Other adverse events
Adverse event data not reported
Additional Information
Dr Sergey Morozov, Senior Reseracher, Dpt Gastroenterology and Hepatology
Federal research Center of Nutrition and Biotechnology
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place